
Commentary|Articles|September 14, 2026
- September 2026
- Volume 92
- Issue 9
OTC Medications and Older Adults: Where the Risks Hide and How Pharmacists Can Help
Author(s)Yvette C. Terrie, BSPharm, RPh
Fact checked by: Nicole Canfora Lupo
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Every day, millions of Americans use an array of nonprescription drugs for routine management of mild to moderate symptoms of various conditions and as preventive measures for proactive self‑care and to promote overall health and well-being. Older adults, typically defined as individuals 65 years and older, represent one of the leading patient populations that utilize nonprescription drugs.1
Related to this article

October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.

CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.

VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.

Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.

Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.

From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.

Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Advertisement
Advertisement

